D.E. Shaw & Co
DNA icon

D.E. Shaw & Co’s Ginkgo Bioworks DNA Stock Holding History

D.E. Shaw & Co’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Sell
27,169
-6,603
-20% -$54.9K ﹤0.01% 4231
2025
Q4 		$281K Buy
+33,772
New +$364K ﹤0.01% 4184
2025
Q3 		– Sell
-59,771
Closed -$715K – 4635
2025
Q2 		$672K Buy
+59,771
New +$463K ﹤0.01% 3490
2025
Q1 		– Sell
-546,418
Closed -$5.37M – 4365
2024
Q4 		$5.37M Sell
546,418
-326,233
-37% -$2.8M ﹤0.01% 1919
2024
Q3 		$7.11M Buy
872,651
+438,742
+101% +$4.4M 0.01% 1671
2024
Q2 		$5.8M Buy
433,909
+431,780
+20,281% +$12.9M 0.01% 1737
2024
Q1 		$98.8K Sell
2,129
-7,880
-79% -$408K ﹤0.01% 4009
2023
Q4 		$677K Buy
10,009
+9,740
+3,621% +$596K ﹤0.01% 3374
2023
Q3 		$19.5K Buy
+269
New +$21.5K ﹤0.01% 3994
2023
Q2 		– Sell
-270
Closed -$14.4K – 4301
2023
Q1 		$14.4K Sell
270
-390
-59% -$24.7K ﹤0.01% 4192
2022
Q4 		$44.6K Buy
+660
New +$60.7K ﹤0.01% 4450
2022
Q3 		– Sell
-285
Closed -$27K – 5257
2022
Q2 		$27K Sell
285
-55,009
-99% -$6.71M ﹤0.01% 4952
2022
Q1 		$8.91M Buy
55,294
+48,137
+673% +$9.37M 0.01% 1703
2021
Q4 		$2.38M Sell
7,157
-15,198
-68% -$7.22M ﹤0.01% 3198
2021
Q3 		$10.4M Buy
+22,355
New +$10.9M 0.01% 1489

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's DNA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Ginkgo Bioworks (DNA) stake by 20% in Q1 2026, selling an estimated $54.9K and leaving 27,169 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #4231.

D.E. Shaw & Co first reported a position in DNA in Q3 2021 and has held it in 15 quarters since. The position peaked at $10.4M in Q3 2021. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • D.E. Shaw & Co held 27,169 shares of Ginkgo Bioworks worth $167K as of Q1 2026.
  • D.E. Shaw & Co sold 6,603 Ginkgo Bioworks shares in Q1 2026, an estimated $54.9K.
  • Ginkgo Bioworks made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4231 holding.
  • D.E. Shaw & Co first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 15 quarters since.
  • D.E. Shaw & Co's Ginkgo Bioworks position peaked at $10.4M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.